Creating optimal asset development strategies to give the best chance of regulatory and commercial success
Adnovate Clinical
Formed at the end of 2014, Adnovate Clinical is a science-led clinical development consultancy servicing the life sciences sector. Our expert drug developers partner with life science companies to identify development strategies that give their assets the best chance of regulatory and commercial success.
We complement the skill sets of internal teams, providing trusted leadership and expertise to unlock the full potential of assets and maximise value creation throughout the clinical development life cycle to commercialization.
We add value by taking a hands-on approach and flexibly adapting our support as needs evolve, ensuring a bespoke service and timely access to the right experts throughout the life cycle of each asset.
Our Services
Creation of
Asset Strategy
Adnovate utilizes its wealth of experience in drug development to create comprehensive cross-functional strategies for products across their development life cycle from scientific conception to market access & commercialization.
Asset Development
Adnovate provides industry-leading expertise to help life science companies successfully operationalize their strategy and advance their assets through pre-clinical and clinical development, and regulatory interactions.
Study Execution/Oversight
Adnovate’s clinical operations experts manage and oversee vendors through the set-up and execution of clinical studies at all stages of development, including first-in-human and proof-of-concept studies.
Meet The Team
Expert drug developers across AMER, EMEA and APAC from core clinical/translational development functions. Strong scientists, researchers and strategists with MD, PhD or both and significant functional leadership experience from biotech and pharma.
Why Adnovate Clinical?
Partnering with Us
01
We are ex-leaders from pharma and biotech with MDs, PhDs or both, and 20+ years’ experience each, creating bespoke clinical development and regulatory strategies
02
We understand the differing financial needs of Biotech’s and provide flexible support and a costing model that can be adapted to investment milestones
03
We offer cost-effective
operational strategies with appropriate vendor selection, and partner to provide oversight with a flexible, hands-on approach
04
We bring together cross-functional expertise across a broad range of TAs for small molecules, biologics & combination therapies;
timely staffing and minimal effort for the client
05
We have a comprehensive understanding of evolving risks throughout the clinical development life cycle, with the necessary experience to address them effectively
06
We deliver innovative development strategies with the end-game in mind, to increase chances of regulatory and commercial success
Supporting growth and
maximizing chances of success
The team at Adnovate provided dependable and strong scientific support whilst adopting a flexible working and financial model as funding was being secured. The high-quality deliverables they produced helped with execution of forward strategy as well as providing the basis of some of the materials used to support fundraising.
Gareth HicksCEO, Viscera
With Adnovate we instantly created a turn-key clinical development function in the company. Every member of the Adnovate team was of top quality and served as a model for what we would later look for when recruiting our own internal team.
Diego ReyCSO, Endpoint Health
The Adnovate team throughout this period functioned as extension of the GEXVal Inc/GEXVal AU Pty Ltd internal team supporting not only the clinical study execution but strategic planning of the product and additions to the quality management system as needed.
Juran KatoCEO, GexVAL Inc
Adnovate were crucial in the successful transition of Unicyte’s lead stem cell therapy to the clinic. They have also been a key part of the exosome-based platform team developing the translational strategy and executing the operational aspects in preparation for the FiH study.
Colin BuckCOO, Unicyte
The Adnovate team produced detailed and thoughtful assessments to meet our needs in our survey of the landscape of development possibilities. This collaborative effort allowed us to prioritize indications that were suitable for our execution. Adnovate’s experienced team members performed professionally and flexibly, maintaining outputs to agreed timelines, and producing high quality deliverables to help with our strategic development planning.
Brihad AbhyankarSVP Clinical Development, Morphic Therapeutic, Inc
Are you interested in joining Adnovate Clinical?
We are a high-impact consultancy looking for talented individuals to join our dynamic team of experts
Scientific Project Lead
We are looking for a translational and/or clinical development scientist/strategist (MD/PhD) who will be responsible for the scientific and technical leadership of assigned consulting projects and project teams. The Scientific Project Lead is responsible for ensuring the scientific validity and excellence of projects, and the delivery of client-focused outputs of the highest quality. The role demands a flexible approach adapted to the specific and evolving needs of our clients and their assets in development.
Let’s develop the next generation of medicines together
Our experts are available for an introductory call to learn about your needs and propose ways in which we may support you.